186 related articles for article (PubMed ID: 1840100)
1. Molecular and clinical heterogeneity of adult GM2 gangliosidosis.
Navon R
Dev Neurosci; 1991; 13(4-5):295-8. PubMed ID: 1840100
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.
Paw BH; Kaback MM; Neufeld EF
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2413-7. PubMed ID: 2522660
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Suzuki K; Vanier MT
Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
[TBL] [Abstract][Full Text] [Related]
4. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.
Navon R; Proia RL
Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679
[TBL] [Abstract][Full Text] [Related]
5. Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect.
Navon R; Kolodny EH; Mitsumoto H; Thomas GH; Proia RL
Am J Hum Genet; 1990 Apr; 46(4):817-21. PubMed ID: 2278539
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
7. [Recent advances in molecular genetics of GM2 gangliosidosis].
Wakamatsu N
Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
[TBL] [Abstract][Full Text] [Related]
8. The clinical aspects of adult hexosaminidase deficiencies.
Federico A; Palmeri S; Malandrini A; Fabrizi G; Mondelli M; Guazzi GC
Dev Neurosci; 1991; 13(4-5):280-7. PubMed ID: 1840098
[TBL] [Abstract][Full Text] [Related]
9. A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.
Cao Z; Natowicz MR; Kaback MM; Lim-Steele JS; Prence EM; Brown D; Chabot T; Triggs-Raine BL
Am J Hum Genet; 1993 Dec; 53(6):1198-205. PubMed ID: 7902672
[TBL] [Abstract][Full Text] [Related]
10. Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase.
Paw BH; Moskowitz SM; Uhrhammer N; Wright N; Kaback MM; Neufeld EF
J Biol Chem; 1990 Jun; 265(16):9452-7. PubMed ID: 2140574
[TBL] [Abstract][Full Text] [Related]
11. Mutation in GM2-gangliosidosis B1 variant.
Ohno K; Suzuki K
J Neurochem; 1988 Jan; 50(1):316-8. PubMed ID: 2961848
[TBL] [Abstract][Full Text] [Related]
12. A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease.
Hou Y; McInnes B; Hinek A; Karpati G; Mahuran D
J Biol Chem; 1998 Aug; 273(33):21386-92. PubMed ID: 9694901
[TBL] [Abstract][Full Text] [Related]
13. Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program.
Paw BH; Tieu PT; Kaback MM; Lim J; Neufeld EF
Am J Hum Genet; 1990 Oct; 47(4):698-705. PubMed ID: 2220809
[TBL] [Abstract][Full Text] [Related]
14. Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.
Navon R; Proia RL
Am J Hum Genet; 1991 Feb; 48(2):412-9. PubMed ID: 1825014
[TBL] [Abstract][Full Text] [Related]
15. Presence of beta-hexosaminidase A alpha-chain mRNA in two different variants of GM2-gangliosidosis.
Budde-Steffen C; Steffen M; Siegel DA; Suzuki K
Neuropediatrics; 1988 May; 19(2):59-61. PubMed ID: 2967444
[TBL] [Abstract][Full Text] [Related]
16. W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis.
Petroulakis E; Cao Z; Clarke JT; Mahuran DJ; Lee G; Triggs-Raine B
Hum Mutat; 1998; 11(6):432-42. PubMed ID: 9603435
[TBL] [Abstract][Full Text] [Related]
17. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
Strasberg PM; Clarke JT
Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
[TBL] [Abstract][Full Text] [Related]
18. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
19. The beta-hexosaminidase deficiency disorders: development of a clinical paradigm in the mouse.
Tifft CJ; Proia RL
Ann Med; 1997 Dec; 29(6):557-61. PubMed ID: 9562524
[TBL] [Abstract][Full Text] [Related]
20. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
Myerowitz R
Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]